Teva Pharmaceutical Industries Market Cap 2006-2021 | TEVA

Teva Pharmaceutical Industries market cap history and chart from 2006 to 2021. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Teva Pharmaceutical Industries market cap as of July 26, 2021 is $9.76B.
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $9.764B $16.659B
TEVA Pharmaceuticals USA, the business is to develop, manufacture, and market generic pharmaceuticals. Teva USA sells its products to chains, wholesalers, distributors, hospitals, managed care entities, and government agencies. The company markets a variety of dosage forms, including both extended and immediate release tablets and capsules, creams, ointments, solutions, and suspensions. Key therapeutic areas are the analgesic, anti-infective, cardiovascular, CNS, dermatological and anti-inflammatory categories.
Stock Name Country Market Cap PE Ratio
Dr Reddy's Laboratories (RDY) India $12.079B 37.24
Bausch Health Cos (BHC) Canada $10.261B 6.90
BridgeBio Pharma (BBIO) United States $8.406B 0.00
ASPEN PHARMACR (APNHY) South Africa $5.258B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.452B 13.23
Amphastar Pharmaceuticals (AMPH) United States $0.986B 30.43
Personalis (PSNL) United States $0.919B 0.00
Homology Medicines (FIXX) United States $0.366B 0.00
Sol-Gel Technologies (SLGL) Israel $0.247B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.199B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.186B 0.00
Assembly Biosciences (ASMB) United States $0.138B 0.00
Agile Therapeutics (AGRX) United States $0.099B 0.00
Acasti Pharma (ACST) Canada $0.096B 0.00
Teligent (TLGT) United States $0.044B 0.00
Evoke Pharma (EVOK) United States $0.035B 0.00
China Pharma Holdings (CPHI) China $0.031B 0.00